炎症性肠病遗传风险与疾病严重程度相关
在丹麦全国队列中,研究对3732例克罗恩病和4535例溃疡性结肠炎患者计算炎症性肠病多基因评分,发现较高的遗传负荷与更严重的疾病病程相关,包括炎症标志物升高、住院和手术风险增加;克罗恩病中该关联主要由病变范围介导,而溃疡性结肠炎中不明显。
要点
- 高遗传负荷的炎症性肠病患者疾病病程更严重。
- 克罗恩病中遗传风险与严重程度的关联主要由病变范围介导。
- 溃疡性结肠炎中遗传风险与严重程度的关联独立于病变范围。
核心结论
- 炎症性肠病遗传负荷较高的患者经历更严重的疾病病程。
- 克罗恩病中遗传风险与严重程度的关联很大程度上由病变范围介导,而溃疡性结肠炎中并非如此。
研究设计与样本
- 丹麦全国队列研究,纳入3732例克罗恩病患者和4535例溃疡性结肠炎患者,计算炎症性肠病多基因评分并分析其与疾病结局的关联。
主要发现
- 多基因评分升高与粪便钙卫蛋白和C反应蛋白水平升高、血红蛋白水平降低相关。
- 最高与最低多基因评分五分位比较,克罗恩病大手术风险比为2.74(P=7.19×10-18),溃疡性结肠炎为2.04(P=4.36×10-7)。
- 多基因评分每增加一个标准差,严重疾病的比值比在克罗恩病为1.25(P=3.36×10-9),溃疡性结肠炎为1.33(P=1.40×10-15)。
- 多基因评分与皮质类固醇、免疫调节剂和生物制剂治疗需求增加相关。
临床怎么用
- 多基因评分可能有助于识别疾病病程更严重的炎症性肠病患者。
- 对高遗传负荷患者应加强疾病监测和优化治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Genetic susceptibility to inflammatory bowel disease (IBD) has been widely studied, whereas the genetic contribution to disease progression remains relatively underinvestigated. In a Danish nationwide cohort, we aimed to explore if genetic susceptibility to IBD associated with disease severity. METHODS: We estimated IBD polygenic scores (PGS) for 3732 patients with Crohn's disease (CD) and 4535 patients with ulcerative colitis (UC), and investigated their association with disease outcomes, including inflammatory markers, hospitalizations, major surgeries, and medication use. A composite severity outcome was defined based on the 3 years after diagnosis. Lastly, we evaluated disease extent as a possible mediator. RESULTS: Increased PGS was associated with higher fecal calprotectin and C-reactive protein levels, and decreased hemoglobin levels. When comparing the highest vs lowest PGS quintile, we observed a hazard ratio for major surgery of 2.74 (P = 7.19 × 10-18) in patients with CD and of 2.04 (P = 4.36 × 10-7) in UC. Patients with severe disease had higher PGS than patients with less severe disease (CD, odds ratio = 1.25; P = 3.36 × 10-9; UC, odds ratio = 1.33; P = 1.40 × 10-15 per standard deviation increase in PGS). Additionally, PGS was associated with a higher need for corticosteroids, immunomodulators, and biologic therapies. Adjusting for disease extent reduced the estimated associations for CD but had little impact on observed associations for UC. CONCLUSIONS: Patients with higher genetic burden for developing IBD also experience a more severe disease course. For patients with CD this link was largely mediated by disease extent, however, this was not the case for UC, which suggests a shared genetic architecture between disease susceptibility and severity.
引用
- Vestergaard MV, Allin KH, Nøhr AK, et al. Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course Severity. Gastroenterology. 2026. PMID: 41665577. doi:10.1053/j.gastro.2025.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。